FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest [...]
Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?
Mientras la FDA estudia otro nuevo medicamento contra el alzhéimer, [...]
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly
The modest benefits of the treatment, donanemab, made by Eli [...]
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefits
As the F.D.A. considers a new Alzheimer’s medication, we asked [...]
¿Qué es polifarmacia y cómo tratarla?
Consumir varios medicamentos aumenta el riesgo de efectos secundarios o [...]
Taking Multiple Medications? You May Need to Scale Back.
Many people in the United States are taking five or [...]
¿Se puede tener alzhéimer y no presentar síntomas?
Una propuesta para cambiar los lineamientos de detección de la [...]
Apparently Healthy, but Diagnosed With Alzheimer’s?
New criteria could lead to a dementia diagnosis on the [...]
What to Know About Mild Cognitive Impairment Treatment
There are ways to manage symptoms and slow the progression.
FDA Makes Alzheimer’s Drug Leqembi Widely Accessible
The F.D.A. gave full approval to the drug, but added [...]